These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30688674)

  • 1. Loss of Heterozygosity (LOH) at 17p13 and 22q13 are Shared by Breast and Thyroid Carcinomas for Metastasis.
    Lin X; Finkelstein SD; Silverman JF
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):e16-e19. PubMed ID: 30688674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of loss of heterozygosity in predicting axillary lymph node metastasis of invasive ductal carcinoma of the breast.
    Lin X; Zhu B; Finkelstein SD; Saad RS; Snitchler A; Silverman JF
    Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):116-23. PubMed ID: 22553811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of multifocal papillary thyroid carcinoma.
    Lin X; Finkelstein SD; Zhu B; Silverman JF
    J Mol Endocrinol; 2008 Oct; 41(4):195-203. PubMed ID: 18628356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
    Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
    Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
    Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.
    Nagahata T; Hirano A; Utada Y; Tsuchiya S; Takahashi K; Tada T; Makita M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
    Breast Cancer; 2002; 9(3):208-15. PubMed ID: 12185331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional loss of tumor suppressor genes detected by loss of heterozygosity, but not driver mutations, predicts aggressive lymph node status in papillary thyroid carcinoma.
    Finkelstein S; Timmaraju VA; Samankan S; O'Malley Q; Kapustin D; Spaulding S; Xing M; Matloob A; Beute J; Seo G; Saturno M; Greenberg L; Wein L; Gonzalez-Velazquez C; Doyle S; Levine J; Urken M; Brandwein-Weber M
    Pathol Res Pract; 2023 Nov; 251():154842. PubMed ID: 37890270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of selected genomic areas potentially involved in thyroid neoplasms.
    Oriola J; Halperin I; Mallofré C; Muntané J; Angel M; Rivera-Fillat F
    Eur J Cancer; 2001 Dec; 37(18):2470-4. PubMed ID: 11720845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer.
    Iida A; Kurose K; Isobe R; Akiyama F; Sakamoto G; Yoshimoto M; Kasumi F; Nakamura Y; Emi M
    Genes Chromosomes Cancer; 1998 Feb; 21(2):108-12. PubMed ID: 9491321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell.
    Migdalska-Sęk M; Czarnecka KH; Kusiński M; Pastuszak-Lewandoska D; Nawrot E; Kuzdak K; Brzeziańska-Lasota E
    Mol Diagn Ther; 2019 Jun; 23(3):369-382. PubMed ID: 30747408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
    Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
    Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Loss of heterozygosity at different chromosomes in patients with breast cancer].
    Deng GR; He LW; Lin BY
    Zhonghua Yi Xue Za Zhi; 1994 Jan; 74(1):31-4, 63-4. PubMed ID: 7913405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal cancer.
    Zheng HT; Peng ZH; Zhou CZ; Li DP; Wang ZW; Qiu GQ; He L
    World J Gastroenterol; 2005 Mar; 11(11):1668-72. PubMed ID: 15786547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
    J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.
    Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
    Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity in 73 human thyroid tumors.
    Wozniak A; Wiench M; Olejniczak A; Wloch J; Lachinski A; Lange D; Olczyk T; Jarzab B; Limon J
    Neuro Endocrinol Lett; 2005 Oct; 26(5):521-5. PubMed ID: 16264407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
    Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
    Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of allelic losses at 3p25.1, 13q12, or 17p13.3 with poor prognosis in breast cancers with lymph node metastasis.
    Haga S; Emi M; Hirano A; Utada Y; Kajiwara T; Akiyama F; Sakamoto G; Takahashi K; Tada T; Kasumi F; Miki Y; Nakamura Y
    Jpn J Cancer Res; 2001 Nov; 92(11):1199-206. PubMed ID: 11714444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.